Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H3 histone pseudogene 11 (H3P11) is annotated as a pseudogene related to the family of histone H3 genes. Pseudogenes are segments of DNA that are similar to functional genes but are generally considered non-functional due to mutations or deletions that prevent normal expression or protein production[4]. The canonical histone H3 proteins are critical for chromatin structure, epigenetic regulation, and gene expression in eukaryotic cells[1][2][5]. However, H3P11 is not an active gene and does not encode a functional histone protein. Pseudogenes such as H3P11 have been cataloged in multiple genomic studies, and some are closely related to canonical H3 gene variants by sequence similarity, but do not contribute to chromatin structure or histone-mediated functions[4]. H3P11 is a pseudogene; it does not produce a functional protein and is not considered a drug target or relevant therapeutic receptor, enzyme, transporter, or similar biological molecule. There is no direct role in disease, drug interaction, biomarkers, or safety concerns. The entry for H3P11 is incorrect as a drug target and should be filtered as such in structured databases[4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H3 histone pseudogene 11 (H3P11).